Techinvention

At Techinvention Lifecare limited our commitment to consumer safety is unwavering. If you experience an adverse event from our product, tell your healthcare provider and then report it to us using the contact details below, enabling us to continuously monitor the safety profile of our products and take action whenever required.

TechInvention's Licensed Products

Euvichol Plus (Cholera Vaccine (Inactivated, Oral), I.P)

The vaccine is a liquid formulation of Oral Cholera Vaccine containing O1 and O139 of Vibrio cholerae inactivated by heat or formalin. The vaccine was developed by EuBiologics Co., Ltd, South Korea with the help of International Vaccine Institute (IVI), Korea. The vaccine fulfils the recommendations stipulated in WHO guidelines for Cholera Vaccine.

Indication

Prevention of Cholera caused by Vibrio cholerae but the efficacy against Vibrio cholerae serogroup O139 was not demonstrated.

Instructions for use

  1. The vaccine should be administered to anyone above the age of 1 year.
  2. Two doses of vaccine should be given at an interval of two weeks.
  3. The vaccine is presented as a suspension. Therefore, after shaking the vaccine container rigorously, 1.5 mL of the vaccine should be squirted into the mouth. Take a sip of water if necessary.
  4. The frozen vaccines should not be taken.
  5. The vaccine should not be administered parenterally (intramuscularly, subcutaneously or intravenously). The vaccine is only recommended for oral administration.

Manufactured by: Eubiologics Co., Ltd.
Marketed by: TechInvention Lifecare limited.

Confidentiality and Privacy

Your privacy is important to us.
All AE reports shall be handled with strict confidentiality.
Personal information is protected and used solely for safety monitoring purposes.

Our team includes biotech and vaccine experts – strategists, scientists, and engineers who between them cover the entire scope of the life sciences landscape. Our domain knowledge and expertise have the depth and breadth to tackle a wide spectrum of problems across geographies. The work we do spans over 30 countries across Asia, Africa, the Middle East, the CIS, and Latin America.

Contact Us

For any questions or to report an Adverse Event, please contact our AE Reporting team:

  • Phone: 18008902590
  • Email: feedback@techinvention.biz
  • Download Reporting Form: Please complete the AE Reporting form and send your response to the aforementioned email.